Insights
News Show all
6.1 million euros for “miTarget” – DFG extends funding for another 4 years
Following a positive on-site review in December 2023, the DFG finally announced its decision on March 25, 2024: miTarget will be funded for another four years with a total of almost 6.1 million euros.
Our mission
Patterns of gut microbiome dysbiosis in patients with inflammatory bowel diseases are inconsistent among published studies, probably owing to the heterogeneity of the disease and given the fact that patients enrolled in research studies are often treated and in remission. Therefore, more microbiome studies in “early” (incident) patients that are treatment-naïve and in high-risk individuals are needed. In addition, the microbiome field has to move from association to rather mechanistic studies in order to understand the actual functions and to also prove the associations that serve as hypotheses.
Institute of Clinical Molecular Biology
Kiel University
Rosalind-Franklin-Str. 12
24105 Kiel
Spokesperson
Prof. Dr. rer. nat. Andre Franke
Fon: +49(0)431-500-15112
a.franke@ikmb-uni-kiel.de
Coordination
Annika Gröning
Fon: +49 (0)431 500-15115
a.groening@ikmb.uni-kiel.de
Doctoral qualification programme
Eike Zell
Fon: +49 (0)431 500-15113
e.zell@ikmb.uni-kiel.de